Aadi Bioscience Balance Sheet Health
Financial Health criteria checks 6/6
Aadi Bioscience has a total shareholder equity of $68.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $85.7M and $16.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$62.62m |
| Equity | US$68.87m |
| Total liabilities | US$16.83m |
| Total assets | US$85.70m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 3350's short term assets ($77.3M) exceed its short term liabilities ($15.8M).
Long Term Liabilities: 3350's short term assets ($77.3M) exceed its long term liabilities ($1.0M).
Debt to Equity History and Analysis
Debt Level: 3350 is debt free.
Reducing Debt: 3350 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 3350 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 3350 has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 38.2% each year.